Gotham Makker, Director at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 20,000 shares at $22.53 ($451K) on 2023-11-15, disclosed to the SEC on 2023-11-16.
Open-market sale of $451k RCKT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RCKT | SELL | 2021-06-21 | $3.3M | — | Filing → |